Subscribe To
2 ultra-high-yield energy stocks to buy in 2023 and beyond
These big-time dividend stocks have important catalysts that should fuel future income growth....
January 21, 2023, 7:39 am
Guardant health: positive eclipse data signals more upside
Harnessing the power of a simple blood test (i.e., liquid biopsy), Guardant Health has offered hope for patients through early detection of cancer. Re...
January 20, 2023, 8:25 am
Commodities watchlist: gold’s short-term uptrend still intact!
This week’s catalysts have pushed spot gold (XAU/USD) to new 2023 highs. Can you still jump on the pr...
January 20, 2023, 8:04 am
Amazon's cost-cutting measures ‘a positive first step,' analyst says
MKM Partners Managing Director Rohit Kulkarni joins Yahoo Finance Live anchors Rachelle Akuffo to discuss his rating and price target on Amazon stock,...
January 19, 2023, 2:29 pm
Posco: 2 key catalysts to watch
The first catalyst for PKX is the potential issuance of favorable financial guidance for Q1 2023 when the company reports Q4 2022 earnings in the foll...
January 19, 2023, 10:16 am
Soligenix invited to present at the virtual investor summit event
Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market P...
January 19, 2023, 7:30 am
Forex watchlist: usd/cad’s make or break consolidation
USD/CAD is consolidating near its long-term mid-range levels. Will this week’s catalysts point us to ...
January 19, 2023, 4:55 am
Vanadium co. has two-pillar strategy and multiple catalysts
Source: Streetwise Reports (1/13/23) In conjunction with the release of its third-quarter report, Largo Inc. reported record high-purity vanadium prod...
January 18, 2023, 4:33 pm
Taiwan semiconductor stock forecast for 2023: what to watch for
The key catalysts for TSM include an increase in capacity located outside its home market and further s...
January 18, 2023, 10:58 am
Stock market glued to 2023 highs despite mixed earnings; is this the new bull market?
Stock market indexes chopped sideways near big resistance levels Tuesday, awaiting catalysts later this...
January 17, 2023, 6:04 pm
Daily market commentary: share markets extend their bearish pull-back in europe, alongside asian stocks, and us futures
European Shares Share markets extended their bearish pull-back in Europe on Tuesday, alongside Asian stocks, and US futures, as the slight “risk-off...
January 17, 2023, 9:43 am
Southern copper is red hot this year
On the heels of the rising price of copper, Southern Copper stock is already up a whopping 25% this year. A falling U.S. dollar and the re-opening of ...
January 15, 2023, 9:51 pm
3 oil and gas stocks with huge prospects in 2023
While many investors now believe inflation and elevated energy prices are in the rear-view mirror there are still...
January 13, 2023, 7:34 pm
Several catalysts point to a potential rebound in emerging market equities in 2023
In our analysis, emerging market (EM) equities may have an asymmetric return profile in 2023 given several cat...
January 11, 2023, 7:14 am
Eur/usd: bulls and bears jostle around mid-1.0700s with eyes on us inflation
China inflation decorates calendar, highlighting risk catalysts as the key. EUR/USD treads waters aroun...
January 10, 2023, 10:29 pm
Tilray brands remains a buy at canaccord despite reduced price target
Tilray Inc (NASDAQ:TLRY) remained on the 'Buy' list at Canaccord Genuity (TSX:CF, LSE:CF) but analysts cut their price target following a weaker-tha...
January 10, 2023, 3:54 pm
5 investors betting big on mullen (muln) stock in 2023
Shares of Mullen Automotive (NASDAQ: MULN ) are in full focus, as several catalysts for the electric ve...
January 10, 2023, 3:46 pm
Geron's data allows development of several catalysts
Primary endpoint of 8-week transfusion independence met in the phase 3 IMerge study; Imetelstat was used as a monotherapy to treat patients with lower...
January 9, 2023, 7:01 pm
Novocure: catalysts stacking for more upside
Powered by the robust Phase 3 (LUNAR) trial, NovoCure Limited shares recently rallied over 70% in one trading session. You can expect Tumor Treating F...
January 9, 2023, 1:07 pm
Agios unveils 2023-2026 value-driving catalysts enabling company’s vision to transform patient outcomes in rare diseases
– Consistent and compelling clinical data across rare hematological diseases support five ongoing pivotal trials in thalassemia, sickle cell disease...
January 9, 2023, 1:00 am